Adicet Bio (ACET) Stock: Buy, Sell, or Hold?
ACET - Adicet Bio, Inc. Common Stock
$6.50
-0.14 (-2.11%)
▼
5d:
-27.94%
30d:
-29.81%
90d:
-28.34%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
29d
Get Alerted When ACET Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ACET is down 27.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ACET is down 27.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ACET is currently trading at $6.50, which is considered oversold relative to its 30-day fair value range of $8.17 to $9.69.
Technical Outlook: Technically, ACET is in a uptrend. Immediate support is located at $6.25, while resistance sits at $9.44.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $34.83 (+435.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACET is in a uptrend. Immediate support is located at $6.25, while resistance sits at $9.44.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $34.83 (+435.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$8.17 -
$9.69
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 435.9% below Wall St target ($34.83)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$8.17 -
$9.69
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.25
Resistance Level
$9.44
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.61
Wall Street Target
$34.83
(+435.9%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: October 05, 2026 12:29 AM ET
Data refreshes hourly during market hours. Next update: 1:29 AM
Data refreshes hourly during market hours. Next update: 1:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACET showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
23 analysts |
$84 | 71 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
15 analysts |
$52 | 66 BUY |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 67 BUY |
|
TSHA
Taysha Gene Therapies Inc |
STRONG BUY
13 analysts |
$13 | 59 HOLD |
